Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
-
![Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220811/b82ed6b94b954f55b2d656864217491b.png "Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)")
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
structure -
-
CAS No:
72901-16-7
-
Formula:
C20H17NO3
-
Chemical Name:
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
-
Synonyms:
Monoacetyl bisacodyl;Bisacodyl Impurity C;Bisacodyl related compound C;[4-[(4-hydroxyphenyl)-pyridin-2-ylmethyl]phenyl] acetate;Phenol, 4-((4-(acetyloxy)phenyl)-2-pyridinylmethyl)-;Phenol, 4-[[4-(acetyloxy)phenyl]-2-pyridinylmethyl]-;Bisacodyl impurity C [EP];(+/-)-Monoacetyl bisacodyl;Bisacodyl related compound C [USP];SCHEMBL2021127
-
CAS No:
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) Basic Attributes
319.35388
319.121
2933399090
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) Use and Manufacturing
Desacetyl Bisacodyl is an impurtiy in the preparation of Bisacodyl (B400800), cathartic.
Computed Properties
Molecular Weight:319.4
XLogP3:3.7
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:5
Exact Mass:319.12084340
Monoisotopic Mass:319.12084340
Topological Polar Surface Area:59.4
Heavy Atom Count:24
Complexity:398
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride)
873310-31-7
-
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester)
35888-94-9
-
Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline)
391860-73-4
-
Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) Formula
865792-18-3
-
Atorvastatin Related Compound C (20 mg) (Difluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt) Formula
693793-53-2
-
Atorvastatin Related Compound A (20 mg) (Desfluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt) Formula
433289-83-9
-
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) Structure
111664-35-8
-
TINIDAZOLE RELATED COMPOUND B (20 MG) (1-(2-ETHYL-SULFONYLETHYL)-2-METHYL-4-NITROIMIDAZOLE) Structure
25459-12-5
-
What is Atorvastatin Related Compound D (20 mg) (Epoxide impurity,or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2-carboxylic acid phenylamide)
148146-51-4
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
SDSRequest for Quotation